文献速递胸部肿瘤

肺癌相关基因甲基化在肺癌早期诊断中的作用

[The role of lung cancer related gene methylation in the early diagnosis of lung cancer].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2020-01-01

该研究纳入60例肺癌手术患者与65例肺部良性病变患者,采用甲基化PCR特异性方法检测血液中DAPK、MGMT、APC1A和ECAD基因甲基化水平。结果显示病例组四种基因甲基化检出率均高于对照组,四基因联合检测预测肺癌的AUC为0.829,高于各基因单独检测,提示联合检测有助于提高肺癌诊断价值。

要点

  • 肺癌患者血液中DAPK、MGMT、APC1A和ECAD甲基化检出率均显著高于良性病变患者。
  • 四种基因甲基化联合检测预测肺癌的AUC为0.829,优于任一单基因检测。
  • 多基因甲基化联合检测可能有助于肺癌的早期诊断。

核心结论

  • 多肺癌相关基因甲基化联合检测能够提高对肺癌的诊断价值,有助于肺癌的早期诊断,具有较高的临床应用价值。

研究设计与样本

  • 以60例行外科手术治疗的肺癌患者为病例组,65例同期住院的肺部良性病变患者为对照组。
  • 采用甲基化PCR特异性方法对两组患者血液标本进行DAPK、MGMT、APC1A及ECAD基因甲基化检测。

主要发现

  • 病例组DAPK、MGMT、APC1A和ECAD甲基化检出率分别为68.3%、68.3%、63.3%和65.0%,均高于对照组(均P<0.05)。
  • 多因素Logistic回归显示DAPK(OR=0.709)、MGMT(OR=0.793)、APC1A(OR=0.163)、ECAD(OR=2.047)均为肺癌发病的独立影响因素(均P<0.05)。
  • DAPK、MGMT、APC1A和ECAD甲基化检测预测肺癌的AUC分别为0.623、0.680、0.620和0.648。
  • 4种基因甲基化联合预测肺癌的AUC为0.829,高于各基因甲基化单一预测肺癌的AUC(均P<0.05)。

临床怎么用

  • 在肺癌早期诊断中,可考虑对血液样本联合检测DAPK、MGMT、APC1A和ECAD基因甲基化以提高诊断效能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the application value of lung cancer-related gene methylation in lung cancer diagnosis. Methods: Sixty patients with lung cancer underwent surgery were selected as the case group, and 65 patients with benign lung lesions treated in the same period were recruited as the control group. The methylation levels of lung cancer-related genes including dying-associated protein kinase (DAPK), O-6-methylguanine-DNA methyltransferase (MGMT), APC gene promoter 1A (APC1A) and epithelial mucoprotein gene (ECAD) in the blood samples of two groups of patients were analyzed by methylated PCR-specific method. The relationship between methylation of lung cancer-related genes and lung cancer was analyzed and its diagnostic value in lung cancer was evaluated. Results: The methylation detection rates of DAPK, MGMT, APC1A and ECAD in the case group were 68.3%, 68.3%, 63.3% and 65.0%, respectively, all higher than those of the control group (all P<0.05). The multivariate Logistic regression analysis showed that DAPK (OR=0.709), MGMT (OR=0.793), APC1A (OR=0.163), and ECAD (OR=2.047) were all independent influencing factors for lung cancer (all P<0.05). Analysis of the receiver operating characteristic curve showed that, the area under the curve (AUC) of DAPK, MGMT, APC1A and ECAD methylation test for lung cancer predicting were 0.623, 0.680, 0.620 and 0.648, respectively, while the AUC of the combined four gene methylation for lung cancer predicting was 0.829, higher than the AUC of each gene (all P<0.05). Conclusion: The combined methylation detection of multiple lung cancer related genes can improve the diagnostic value of lung cancer, contribute to the early diagnosis of lung cancer, and have potentially clinical application value. 目的: 探讨肺癌相关基因甲基化在肺癌诊断中的应用价值。 方法: 以60例行外科手术治疗的肺癌患者为病例组对象,65例同期住院的肺部良性病变患者为对照组。采用甲基化PCR特异性方法对两组患者的血液标本进行死亡相关蛋白激酶(DAPK)、6-氧-甲基鸟嘌呤-DNA甲基转移酶(MGMT)、APC基因启动子1A(APC1A)及上皮黏性蛋白基因(ECAD)等肺癌相关基因的甲基化检测,分析肺癌相关基因甲基化与肺癌的关系,评价肺癌相关基因甲基化对肺癌的的诊断效能。 结果: 病例组患者肺癌相关基因DAPK、MGMT、APC1A和ECAD甲基化检出率分别为68.3%、68.3%、63.3%和65.0%,均高于对照组(均P<0.05)。多因素Logistic回归分析显示,DAPK(OR=0.709)、MGMT(OR=0.793)、APC1A(OR=0.163)、ECAD(OR=2.047)均为肺癌发病的独立影响因素(均P<0.05)。采用受试者工作特征曲线分析显示,肺癌相关基因DAPK、MGMT、APC1A和ECAD甲基化检测预测肺癌的曲线下面积分别为0.623、0.680、0.620和0.648,而4种基因甲基化联合预测肺癌的AUC为0.829,均高于各基因甲基化单一预测肺癌的AUC(均P<0.05)。 结论: 多肺癌相关基因甲基化联合检测能够提高对肺癌的诊断价值,有助于肺癌的早期诊断,具有较高的临床应用价值。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li Y, Fan QX. [The role of lung cancer related gene methylation in the early diagnosis of lung cancer]. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 32867455. doi:10.3760/cma.j.cn112152-20190311-00144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。